18 May 2023Big PharmaMuireann Bolger

Sanofi wins enablement showdown at SCOTUS

Case concerned the interpretation of a key requirement of the US Patent Act | Amgen’s ‘roadmap’ held to describe step-by-step its own trial-and-error method for finding functional antibodies.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Amgen v Sanofi: Scotus grapples with enablement

28 March 2023 As the US Supreme Court probed the key issue of enablement in Amgen v Sanofi, patent lawyers shared their views on the much-anticipated hearings.

Big Pharma

Sanofi backed by big pharma and more in SCOTUS clash

More on this story

Americas

Amgen v Sanofi: Scotus grapples with enablement

28 March 2023 As the US Supreme Court probed the key issue of enablement in Amgen v Sanofi, patent lawyers shared their views on the much-anticipated hearings.

Big Pharma

Sanofi backed by big pharma and more in SCOTUS clash

More on this story

Americas

Amgen v Sanofi: Scotus grapples with enablement

28 March 2023 As the US Supreme Court probed the key issue of enablement in Amgen v Sanofi, patent lawyers shared their views on the much-anticipated hearings.

Big Pharma

Sanofi backed by big pharma and more in SCOTUS clash